NATUS MEDICAL INC (NTUS) Stock Price, Forecast & Analysis
USA - NASDAQ:NTUS - US6390501038 - Common Stock
NTUS Key Statistics, Chart & Performance
The current stock price of NTUS is 32.96 USD. In the past month the price increased by 2.07%. In the past year, price increased by 32.69%.
NTUS Latest News, Press Relases and Analysis
NTUS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.45 | 221.04B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.45 | 205.11B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.75 | 151.88B | ||
| SYK | STRYKER CORP | 27.62 | 139.05B | ||
| IDXX | IDEXX LABORATORIES INC | 56.5 | 57.00B | ||
| BDX | BECTON DICKINSON AND CO | 13.11 | 54.18B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.14 | 50.00B | ||
| RMD | RESMED INC | 25.5 | 36.84B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.99 | 33.52B | ||
| PODD | INSULET CORP | 71.4 | 22.97B | ||
| DXCM | DEXCOM INC | 31.25 | 22.80B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.94 | 17.53B |
Related stock screener links
About NTUS
Company Profile
Natus Medical, Inc. provides medical device solutions focuses on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. The company is headquartered in Middleton, Wisconsin and currently employs 1,400 full-time employees. The company went IPO on 2001-07-20. The company provides product solutions for three end markets: Neuro, Newborn Care, and Hearing & Balance. Its Neuro includes products and services that provide diagnostic, therapeutic, and surgical solutions in neurodiagnostic, neurocritical care and neurosurgery. Newborn Care includes products and services for newborn care, including hearing screening, brain monitoring, eye imaging, jaundice management, live video streaming and various disposable newborn care supplies. Hearing & Balance includes products for hearing assessment and diagnostics, and hearing aid fitting, including computer-based audiological, otoneurologic and vestibular instrumentation for hearing care professionals. Its Neuro products and services include Electroencephalography, Electromyography, Polysomnography, Subdural electrodes, and Cranial access kits.
Company Info
NATUS MEDICAL INC
3150 Pleasant View Road
Middleton WISCONSIN 94566 US
CEO: Jonathan A. Kennedy
Employees: 1400
Phone: 16088298500.0
NATUS MEDICAL INC / NTUS FAQ
What does NTUS do?
Natus Medical, Inc. provides medical device solutions focuses on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. The company is headquartered in Middleton, Wisconsin and currently employs 1,400 full-time employees. The company went IPO on 2001-07-20. The company provides product solutions for three end markets: Neuro, Newborn Care, and Hearing & Balance. Its Neuro includes products and services that provide diagnostic, therapeutic, and surgical solutions in neurodiagnostic, neurocritical care and neurosurgery. Newborn Care includes products and services for newborn care, including hearing screening, brain monitoring, eye imaging, jaundice management, live video streaming and various disposable newborn care supplies. Hearing & Balance includes products for hearing assessment and diagnostics, and hearing aid fitting, including computer-based audiological, otoneurologic and vestibular instrumentation for hearing care professionals. Its Neuro products and services include Electroencephalography, Electromyography, Polysomnography, Subdural electrodes, and Cranial access kits.
Can you provide the latest stock price for NATUS MEDICAL INC?
The current stock price of NTUS is 32.96 USD. The price increased by 0.09% in the last trading session.
What is the dividend status of NATUS MEDICAL INC?
NTUS does not pay a dividend.
What is the ChartMill technical and fundamental rating of NTUS stock?
NTUS has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the GICS sector and industry of NTUS stock?
NATUS MEDICAL INC (NTUS) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
How is the valuation of NATUS MEDICAL INC (NTUS) based on its PE ratio?
The PE ratio for NATUS MEDICAL INC (NTUS) is 26.16. This is based on the reported non-GAAP earnings per share of 1.26 and the current share price of 32.96 USD.
Can you provide the growth outlook for NATUS MEDICAL INC?
The Revenue of NATUS MEDICAL INC (NTUS) is expected to grow by 5.1% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
NTUS Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to NTUS. When comparing the yearly performance of all stocks, NTUS is one of the better performing stocks in the market, outperforming 93.25% of all stocks.
NTUS Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to NTUS. NTUS has an excellent financial health rating, but there are some minor concerns on its profitability.
NTUS Financial Highlights
Over the last trailing twelve months NTUS reported a non-GAAP Earnings per Share(EPS) of 1.26. The EPS increased by 147.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.65% | ||
| ROA | 2.23% | ||
| ROE | 2.94% | ||
| Debt/Equity | 0 |
NTUS Forecast & Estimates
For the next year, analysts expect an EPS growth of 22.4% and a revenue growth 5.1% for NTUS